Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency: perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemic
The challenges of providing alpha 1 antitrypsin therapy during the COVID-19 pandemic and the potential considerations for its implementation thereafter
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 November 2021
|
| In: |
The International journal of chronic obstructive pulmonary disease
Year: 2021, Jahrgang: 16, Pages: 2983-2996 |
| ISSN: | 1178-2005 |
| DOI: | 10.2147/COPD.S325211 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S325211 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/alpha-1-antitrypsin-therapy-in-patients-with-alpha-1-antitrypsin-defic-peer-reviewed-fulltext-article-COPD 
|
| Verfasserangaben: | Felix JF Herth, Robert A. Sandhaus, Alice M. Turner, Maria Sucena, Tobias Welte, Timm Greulich |
| Zusammenfassung: | The challenges of providing alpha 1 antitrypsin therapy during the COVID-19 pandemic and the potential considerations for its implementation thereafter |
|---|---|
| Beschreibung: | Gesehen am 04.10.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1178-2005 |
| DOI: | 10.2147/COPD.S325211 |